Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

Stewart, J S; Hird, V; Snook, D; Dhokia, B; Sivolapenko, G; Hooker, G; Papadimitriou, J T; Rowlinson, G; Sullivan, M; Lambert, H E

Stewart, J S; Hird, V; Snook, D; Dhokia, B; Sivolapenko, G; Hooker, G; Papadimitriou, J T; Rowlinson, G; Sullivan, M; Lambert, H E.

Affiliation

Stewart JS; Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.

J Clin Oncol ; 8(12): 1941-50, 1990 Dec.

Article in En | MEDLINE | ID: mdl-2230887

Subject(s)

Immunotoxins/pharmacokinetics; Ovarian Neoplasms/metabolism; Yttrium Radioisotopes/pharmacokinetics; Adult; Aged; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/pharmacokinetics; Antibodies, Monoclonal/therapeutic use; Bone Marrow/radiation effects; Female; Humans; Immunotoxins/administration & dosage; Immunotoxins/therapeutic use; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms/drug therapy; Radiotherapy Dosage; Remission Induction; Yttrium Radioisotopes/administration & dosage; Yttrium Radioisotopes/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Yttrium Radioisotopes / Immunotoxins Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1990 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links